In July of 2022, AllCells was acquired by Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists™. By combining over 30 years of cell and gene therapy (CGT) expertise, our clients now have access to an enhanced donor collection network, the world’s largest biospecimen inventory, and a wide range of multi-omic biomarker services. AllCells’ proven […]